These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 19419201

  • 1. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J, Lee DC, Law AH, Yang CL, Poon LL, Lau AS, Jones SJ.
    J Med Chem; 2009 May 14; 52(9):2667-72. PubMed ID: 19419201
    [Abstract] [Full Text] [Related]

  • 2. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS, Wang SQ, Chou KC.
    Biochem Biophys Res Commun; 2007 Oct 19; 362(2):525-31. PubMed ID: 17707775
    [Abstract] [Full Text] [Related]

  • 3. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S, Schweiger B.
    J Virol Methods; 2008 Nov 19; 153(2):134-41. PubMed ID: 18725246
    [Abstract] [Full Text] [Related]

  • 4. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H, Kawai N.
    Expert Rev Anti Infect Ther; 2011 Oct 19; 9(10):851-7. PubMed ID: 21973296
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM.
    Biophys Chem; 2009 Mar 19; 140(1-3):35-8. PubMed ID: 19117662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M, de Jong MD.
    Antivir Ther; 2007 Mar 19; 12(4 Pt B):593-602. PubMed ID: 17944267
    [Abstract] [Full Text] [Related]

  • 9. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW, Jo WH.
    J Chem Inf Model; 2009 Dec 19; 49(12):2735-41. PubMed ID: 19957991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T, Malaisree M, Udommaneethanakit T, Hannongbua S.
    Biophys Chem; 2009 Apr 19; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.
    Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Véron M, van der Werf S, Naffakh N.
    Antimicrob Agents Chemother; 2006 Nov 19; 50(11):3809-15. PubMed ID: 16940075
    [Abstract] [Full Text] [Related]

  • 14. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
    García-Sosa AT, Sild S, Maran U.
    J Chem Inf Model; 2008 Oct 19; 48(10):2074-80. PubMed ID: 18847186
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW, Jo WH.
    Eur J Med Chem; 2010 Feb 19; 45(2):536-41. PubMed ID: 19914748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.